Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Decisions in HIV Care: Weight Gain in ART

Listen as Joseph J. Eron, Jr., MD, explores whether weight gain should or should not be a factor in determining initial therapy.
Joseph J. Eron, Jr., MD
Released: August 30, 2021

In this episode, Joseph J. Eron, Jr., MD, explores whether weight gain should or should not be a factor in determining initial therapy.

Listen as he gives his perspectives on:

  • Weight gain following ART initiation by ARV class and ARV drug
  • Results of the ADVANCE and GEMINI-1 and -2 studies, with exploration of weight, risk of CVD and diabetes
  • BMI changes in PWH
  • DHHS and IAS-USA guidelines for initial therapy

Information on this Educational Activity

Faculty

Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, Merck, Trio Health, and ViiV and funds for research support from Gilead Sciences, Janssen, and ViiV.

Program Medium

This program has been made available online.

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Audio from Dr. Jason Halperin and Clinical Care Options (CCO): medication treatment for OUD improves HIV viral suppression rates on ART

Jason Halperin, MD, MPH Released: September 23, 2021

Audio from Dr. Jason Halperin and Clinical Care Options (CCO): timely ART for adolescents leads to virologic suppression and upholds equity

Jason Halperin, MD, MPH Released: September 23, 2021

Clinical Care Options’ (CCO) commentary on patient education for people living with HIV during the COVID-19 pandemic

Sharon L. Walmsley, MSc, MD, FRCPC Released: September 22, 2021

From Dr. Eric Daar and CCO, slides covering new data from IAS 2021 expanding our understanding of the adverse event profiles of specific ART regimens

Eric S. Daar, MD Released: September 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue